The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 07, 2026
Filed:
Nov. 25, 2020
Applicant:
Disarm Therapeutics, Inc., Cambridge, MA (US);
Inventors:
Liza Leventhal, Lexington, MA (US);
Thomas Engber, Cambridge, MA (US);
Raul Eduardo Krauss, Chestnut Hill, MA (US);
Rajesh Devraj, Chesterfield, MO (US);
Robert Owen Hughes, Newtown, CT (US);
Todd Bosanac, New Milford, CT (US);
Sudhir Agrawal, Shrewsbury, MA (US);
Marco A. Passini, Northborough, MA (US);
Assignee:
DISARM THERAPEUTICS, INC., Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); A61P 25/28 (2006.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61P 25/28 (2018.01); C12N 2310/11 (2013.01); C12N 2310/3125 (2013.01); C12N 2310/314 (2013.01); C12N 2310/315 (2013.01); C12N 2310/316 (2013.01); C12N 2310/531 (2013.01);
Abstract
The present invention relates to compositions and methods for treating neurodegeneration and neurodegenerative diseases associated with axonal degeneration. Neurodegeneration and neurodegenerative diseases associated with axonal degeneration are treated with therapies comprising SARM1 inhibitors such as SARM1 antisense oligonucleotides.